Animal-Assisted Therapy in the Residential Treatment of Schizophrenia and Addictions

Miguel Monfort Montolio160 enrolled

Overview

Animal-assisted therapy (AAT) is a complementary intervention of therapy that has shown positive results in the treatment of various pathologies. This study assesses the viability of the implementation and the efectiveness of an AAT program in patients diagnosed with substance abuse disorder and associated mental disorders (dual pathology).

Animal assisted therapy (AAT) is a complementary intervention to therapy that presents positive results in the treatment of different pathologies. The study assesses the implementation and effectiveness of a TAA program in patients diagnosed with substance use disorder and schizophrenia spectrum disorder.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

160

Conditions

Diagnosis, Dual (Psychiatry)

Interventions

Animal-assisted therapy (AAT)BEHAVIORAL

usual treatmentOTHER

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Meeting DSM-5 criteria for substance abuse disorder and the presence of schizophrenia * Voluntary participant in the study and having signed the informed consent Exclusion Criteria: * Patients whose functioning could be altered by factors not specifically related to addictive pathology or mental disorder (severe cognitive impairment, intellectual deficiency or language barrier) * Animal-specific phobia

Outcomes

Primary Outcomes

The Life Skills Profile questionnaire (LSP)

This questionnaire evaluates aspects of functioning that affect daily activities and the adaptation of people with mental illnesses in the community. It contains 39 items that are grouped into self-care, social-interpersonal behaviour, communication-social contact, non-personal social behaviour and autonomous life

Time frame: Change from Life Skills at 3-6-9 months (12 minutes)

Barrat impulsiveness scale (BIS-11)

This instrument is composed of 30 items distributed into three sub-scales: nonplanning, motor and attentional. The total impulsiveness score was also obtained.

Time frame: Change from impulsiveness at 3-6-9 months (12 minutes)

Calgary Depresión Scale for Schizophrenia (CDSS)

El cuestionario es un intrumento estructurado, adminisitrado por un clínico de forma heteroaplicada para población adulta, con un tiempo aproximado de administración de entre 10 y 30 minutos, y aborada el área terapéutica relativa a la sintomatología de los trastornos depresivos.

Time frame: Change from Depresión at 3-6-9 months (12 minutes)

Rosenberg Self-Esteem Scale

The questionnaire consists of 10 statements of the feelings that the person has about himself. Five of the statements are addressed positively (items 1, 2, 4, 6 and 7) and 5 negatively (items 3, 5, 8, 9 and 10).

Time frame: Change from self.-esteem at 3-6-9 months (12 minutes)

Positive and negative symptom scale (PANSS)

It is a semi-structured and hetero-applied questionnaire for the adult population. The application time is between 30-60 minutes and evaluates the positive and negative symptoms of schizophrenia and other psychotic disorders.

Time frame: Change from Positive and negative symptom at 3-6-9 months (12 minutes)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.